1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
TERMINATION OF ABNORMAL INTRAUTERINE PREGNANCIES WITH INTRAMUSCULAR ADMINISTRATION OF DIHOMO 15 METHYL PROSTAGLANDIN F2α
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1976.tb00767.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 83, Issue 11, pages 885–889, November 1976
Additional Information
How to Cite
Karim, S. M. M. and Ratnam, S. S. (1976), TERMINATION OF ABNORMAL INTRAUTERINE PREGNANCIES WITH INTRAMUSCULAR ADMINISTRATION OF DIHOMO 15 METHYL PROSTAGLANDIN F2α. BJOG: An International Journal of Obstetrics & Gynaecology, 83: 885–889. doi: 10.1111/j.1471-0528.1976.tb00767.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Abstract
- References
- Cited By
Summary
A synthetic compound, 2a, 2b dihomo 15 (S) 15 methyl prostaglandin F2α methyl ester given 8 hourly by intramuscular injection was used to terminate pregnancies in 72 patients with a missed abortion, intrauterine fetal death, molar or anencephalic pregnancies. Treatment was successful in all cases. A 4 mgdose of loperamide given orally at 15 to 30 minutes before the injection of prostaglandin analogue prevented diarrhoea as a side effect.